Treatment with Isturisa (osilodrostat) is generally well tolerated and effective at reducing cortisol levels and easing Cushing’s disease…
Andrea Lobo
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo
A rare, highly malignant kidney tumor turned out to be the cause of Cushing’s syndrome in an 18-year-old man whose…
A new report from researchers at the Montefiore Medical Center in New York details the cases of two women with…
A low-dose dexamethasone test, which is commonly used to diagnose Cushing’s syndrome, can effectively detect the rare condition in…
In what researchers describe as an “exceedingly rare” case, adrenocorticotropic hormone (ACTH)-producing advanced adrenal gland cancer was determined to be…
The rare case of a 14-year-old girl who experienced spontaneous remission of Cushing’s disease after pituitary tumor apoplexy has…
An invasive tumor in the thymus turned out to be the cause of a 31-year-old woman’s severe ectopic, adrenocorticotropic hormone…
Mutations in the USP8 gene are found in 35% of the pituitary corticotroph adenomas that cause Cushing’s disease, and…
A protein found in tissues that produce and release hormones may be a biomarker to help distinguish Cushing’s disease…
Among people with endogenous Cushing’s syndrome whose high blood pressure, or hypertension, dropped after five months on relacorilant, that…